100% Secure Payments
Tender Details
- Country: USA
- Summary: Assay Validation of High Quality Markers for Clinical Studies in Cancer (Uh2/Uh3 Clinical Trial not Allowed)
- UST Ref No: 46537931
- Deadline: 10 Oct 2023
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: -
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PAR-20-313
- Purchaser's Detail :
- Description :
- Tender are invited for Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
CFDA Number : 93.394 -- Cancer Detection and Diagnosis Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Oct 10, 2023
Posted Date : Oct 13, 2020
Description: Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications to support the validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control. This FOA will support investigator-initiated research for both analytical, and clinical validation of assays to be used in cancer treatment, control, or prevention trials supported by the NCI. This FOA will also support the validation of pharmacodynamic markers and markers of toxicity. Applicants should have assays that work on human samples and whose importance is well justified for development into clinical assays. As chemotherapies and/or radiation therapies are increasingly combined with immunotherapies to enhance thedurability of anti-cancer responses, assays for measuring multiple markers, including immune markers, can be developed and validated simultaneously. The UH2 phase of this FOA supports analytical validati... - Documents :
Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Email :FBOWebmaster@OD.NIH.GOV
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
